Homology Medicines is based in Bedford, Massachusetts. It has raised $456M in total funding. Latest round: Growth.
Homology Medicines funding overview
Homology Medicines is based in Bedford, Massachusetts. Homology Medicines has raised $456M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Growth announced in March 2024. The round record for Homology Medicines runs through 2024; nothing later has been disclosed. Investors on record include 5AM Ventures, ARCH Venture Partners, Temasek, Deerfield Management. 4 distinct backers are named across the disclosed rounds.
Homology Medicines has raised $456M in total disclosed funding across the rounds on record.
Who has invested in Homology Medicines?
5AM Ventures, ARCH Venture Partners, Temasek, Deerfield Management are named among the investors backing Homology Medicines.
What was the latest Homology Medicines funding round?
The most recent disclosed round is a Growth, announced in March 2024.
Where is Homology Medicines based?
Homology Medicines is based in Bedford, Massachusetts.
When did Homology Medicines last raise?
The last disclosed Homology Medicines round closed in March 2024 at Growth.
Homology Medicines totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Bedford below to benchmark round size and investor mix.
